Robust Customer Demand and Strong Execution
Drove Record Annual Revenues and EPS
BEVERLY,
Mass., Jan. 10, 2023 /PRNewswire/ -- Axcelis
Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling
ion implantation solutions for the semiconductor industry, today
provided updated financial guidance for the fourth quarter of 2022
and the full year 2022. The Company expects revenue for the fourth
quarter of 2022 to exceed $250
million, above prior guidance of approximately $232-240 million, and to deliver full year 2022
revenue above $900 million. Earnings
per diluted share are forecasted to be greater than $1.45 for the fourth quarter, up from the
previous guidance of approximately $1.00-1.10. The Company expects earnings per
diluted share of greater than $5.00
for the full year 2022.
President and CEO Mary Puma
commented, "Our performance in the fourth quarter was a result
of strong execution by Axcelis employees delivering higher than
expected system shipments and aftermarket revenue. Favorable FX
also positively impacted our earnings per share in the quarter."
Puma continued, "We expect year over year growth in 2023 based on
robust demand for the Purion product family, especially in the
power device segment."
Fourth Quarter and Full Year 2022 Conference Call
Axcelis Technologies will release financial results for the
fourth quarter and full year 2022 on Monday, February 6,
2023, at 4:00 p.m. Eastern Time (ET). The Company
will host a call to discuss the results for the fourth quarter and
full year 2022 on Tuesday, February 7,
2023, at 8:30 a.m. ET. The
call will be available to interested listeners via an audio webcast
that can be accessed through the Investors page of Axcelis' website
at www.axcelis.com, or by registering as a Participant here:
https://register.vevent.com/register/BI2c9198cd02354e0fb92ddec100489c61.
Webcast replays will be available for 30 days following the
call.
Safe Harbor Statement
This press release contains forward-looking statements under the
SEC safe harbor provisions. These statements, which include our
guidance for future reports of financial performance, are based on
management's current expectations and should be viewed with
caution. They are subject to various risks and uncertainties, many
of which are outside the control of the Company, including the
timing of orders and shipments, the conversion of orders to revenue
in any particular quarter, or at all, the continuing demand for
semiconductor equipment, relative market growth, continuity of
business relationships with and purchases by major customers,
competitive pressure on sales and pricing, increases in material
and other production costs that cannot be recouped in product
pricing and global economic, political and financial conditions.
These risks and other risk factors relating to Axcelis are
described more fully in the most recent Form 10-K filed by
Axcelis and in other documents filed from time to time with the
Securities and Exchange Commission.
About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative,
high-productivity solutions for the semiconductor industry for over
40 years. Axcelis is dedicated to developing enabling process
applications through the design, manufacture and complete life
cycle support of ion implantation systems, one of the most critical
and enabling steps in the IC manufacturing process. Learn more
about Axcelis at www.axcelis.com.
CONTACT:
Maureen Hart (editorial/media)
978.787.4266,
Doug Lawson (investor relations)
978.787.9552
View original content to download
multimedia:https://www.prnewswire.com/news-releases/axcelis-updates-and-increases-q4-2022-and-full-year-2022-guidance-301718212.html
SOURCE Axcelis Technologies, Inc.